Results
|
|
61.
|
|
|
|
62.
|
|
|
|
63.
|
|
|
|
64.
|
|
|
|
65.
|
|
|
|
66.
|
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies. [electronic resource] by
- Van Wijmeersch, Bart
- Singer, Barry A
- Boster, Aaron
- Broadley, Simon
- Fernández, Óscar
- Freedman, Mark S
- Izquierdo, Guillermo
- Lycke, Jan
- Pozzilli, Carlo
- Sharrack, Basil
- Steingo, Brian
- Wiendl, Heinz
- Wray, Sibyl
- Ziemssen, Tjalf
- Chung, Luke
- Margolin, David H
- Thangavelu, Karthinathan
- Vermersch, Patrick
Producer: 20210924
In:
Multiple sclerosis (Houndmills, Basingstoke, England) vol. 26
Availability: No items available.
|
|
|
67.
|
|
|
|
68.
|
|
|
|
69.
|
|
|
|
70.
|
|
|
|
71.
|
|
|
|
72.
|
|
|
|
73.
|
|
|
|
74.
|
|
|
|
75.
|
|
|
|
76.
|
|
|
|
77.
|
|
|
|
78.
|
|
|
|
79.
|
|
|
|
80.
|
|